Inhibikase Therapeutics Current Ratio 2011-2026 | IKT

Annual Current Ratio Inhibikase Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.11	6.39	10.5	3.41	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.5	3.41	6.1

Quarterly Current Ratio Inhibikase Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.9	10.1	11	26.4	0.89	2.37	2.58	4.11	6.25	7.75	9.91	6.39	8.3	7.57	8.76	10.5	16.9	22.8	3.09	2.96	2.96	2.96	2.96	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
26.4	0.89	8.24

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	3.48	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Acer Therapeutics ACER	0.41	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
ADMA Biologics ADMA	4.25	$ 15.36	-2.17 %	$ 3.66 B	USA
Cellectis S.A. CLLS	1.52	$ 3.53	-3.54 %	$ 116 M	France
AgeX Therapeutics AGE	1.81	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	1.52	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	2.67	-	-	$ 2.17 B	USA
Nymox Pharmaceutical Corporation NYMX	0.088	-	-19.68 %	$ 18.4 M	Canada
AlloVir ALVR	22.6	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	3.71	$ 0.79	-1.15 %	$ 4.31 M	China
Autolus Therapeutics plc AUTL	2.2	$ 1.51	1.35 %	$ 385 M	Britain
China SXT Pharmaceuticals SXTC	3.48	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	6.37	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	2.41	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Anika Therapeutics ANIK	14.4	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	1.5	$ 74.36	-1.64 %	$ 1.44 B	USA
Applied Therapeutics APLT	0.762	-	-	$ 8.42 M	USA
Aravive ARAV	1.21	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	28.7	-	1052.0 %	$ 415 M	USA
Athersys ATHX	2.38	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	1.77	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	1.15	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	0.507	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	0.311	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	13.4	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	0.191	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	2.37	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	2.14	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	1.47	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	6.32	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	2.69	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
BioLineRx Ltd. BLRX	1.53	$ 2.69	-0.74 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	5.04	$ 61.3	1.21 %	$ 11.8 B	USA
Burford Capital Limited BUR	2.14	$ 7.79	-5.75 %	$ 1.28 B	Britain
CymaBay Therapeutics CBAY	3.05	-	-	$ 3.45 B	USA